GUTS ▲ +12.7% - Fractyl Health, Inc.
$GUTS Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
16-OCT-2026 07:01 AM ET
Share this post
More filings for $GUTS
GUTS ▼ -4.5% - Fractyl Health, Inc.Oct 29, 2026GUTS ▲ +1.7% - Fractyl Health, Inc.Oct 22, 2026GUTS ▲ +12.7% - Fractyl Health, Inc.Oct 16, 2026
View full $GUTS filing history →💬 Comments
Loading comments…
Leave a comment
